Study: Lynparza can reduce relapse, death in some breast cancer patients


In a study published last week in The New England Journal of Medicine, British drugmaker AstraZeneca said that in a late-stage trial, its drug Lynparza reduced the risk of relapse and death in breast cancer patients with certain gene mutations.
Lynparza was developed with Merck, and works to inhibit PARP, a protein that repairs DNA damage to cells — including those that are cancerous. It can be given as a maintenance therapy or an active treatment after chemotherapy. The study found that compared to a placebo, Lynparza reduced the combined risk of recurrence of breast cancer or death from any cause by 42 percent, Reuters reports.
Globally, breast cancer is now the most common form of the disease, the World Health Organization said in February, accounting for almost 12 percent of new cases every year.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Gandhi arrests: Narendra Modi's 'vendetta' against India's opposition
The Explainer Another episode threatens to spark uproar in the Indian PM's long-running battle against the country's first family
By Harriet Marsden, The Week UK
-
How the woke right gained power in the US
Under the radar The term has grown in prominence since Donald Trump returned to the White House
By Chas Newkey-Burden, The Week UK
-
Codeword: April 24, 2025
The Week's daily codeword puzzle
By The Week Staff
-
Scientists find hint of alien life on distant world
Speed Read NASA's James Webb Space Telescope has detected a possible signature of life on planet K2-18b
By Peter Weber, The Week US
-
Katy Perry, Gayle King visit space on Bezos rocket
Speed Read Six well-known women went into lower orbit for 11 minutes
By Peter Weber, The Week US
-
Scientists map miles of wiring in mouse brain
Speed Read Researchers have created the 'largest and most detailed wiring diagram of a mammalian brain to date,' said Nature
By Peter Weber, The Week US
-
Scientists genetically revive extinct 'dire wolves'
Speed Read A 'de-extinction' company has revived the species made popular by HBO's 'Game of Thrones'
By Peter Weber, The Week US
-
Dark energy may not doom the universe, data suggests
Speed Read The dark energy pushing the universe apart appears to be weakening
By Peter Weber, The Week US
-
Life after space: how will Nasa's stranded astronauts cope?
In the Spotlight Sunita 'Suni' Williams and Barry 'Butch' Wilmore are headed back to Earth after nine months on the ISS – but their greatest challenge may still lie ahead
By Harriet Marsden, The Week UK
-
Pharaoh's tomb discovered for first time in 100 years
Speed Read This is the first burial chamber of a pharaoh unearthed since Tutankhamun in 1922
By Peter Weber, The Week US
-
Scientists report optimal method to boil an egg
Speed Read It takes two temperatures of water to achieve and no fancy gadgets
By Peter Weber, The Week US